A new acquisition by DRI Healthcare (DRI Healthcare Stock Quote, Chart, News, Analysts, Financials TSX:DHT.UN) is being viewed positively at Raymond James. On October 2, DRI reported that it had acquired gene-editing technology from Editas Medicine. “We are excited to further diversify our portfolio into a new therapeutic area,” acting CEO Ali Hedayat said. “The […]
After a series of marketing meetings with management, Paradigm Capital analyst Daniel Rosenberg has maintained his “Buy” rating on Converge Technology Solutions (Converge Technology Solutions Stock Quote, Chart, News, Analysts, Financials TSX:CTS). “Yesterday, we hosted marketing meetings with Greg Berard, CEO, and Avjit Kamboj, CFO,” the analyst wrote. “The meetings highlighted Converge’s operational updates, capital […]
Share
Tweet
Share
